Podcast


Presenter: G. Michael Allan MD CCFP James McCormack BSc (Pharm) Pharm D Ricky D. Turgeon BSc(Pharm) ACPR PharmD

In episode 494, Mike and James invite Ricky Turgeon to talk about a potential new use for an old drug – colchicine. Ricky explains all the evidence we have for low-dose colchicine in people with a history of cardiovascular disease. We find out that colchicine reduces the risk of a cardiovascular event in a similar…

This content is for *CFPC Member Rate, CFPC Member Rate, Non-CFPC Member Rate, and Resident members only.
Login Join Now



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

BS Medicine Episode #539: You have prostate cancer – now what?

In episode 539, James and Mike focus in a PREMIUM way on the latest prostate cancer intervention trial. Patients with prostate cancer were randomized to active monitoring, surgery, or radiotherapy…
Listen 0.5 credits available

BS Medicine Episode #538: Egging you on to look at the evidence around eggs

In episode 538, James and Mike discuss the great (but pretty much silly) egg controversy. We go over the best available evidence for eggs which is at best not great.…
Listen 0.5 credits available

BS Medicine Episode #537: A Jab for Your CAD: Influenza vaccination for the prevention of cardiovascular events

In episode 537, Mike and James invite Ricky Turgeon back to the podcast to talk about the impact of the influenza vaccination on cardiovascular events in both primary and secondary…
Listen 0.5 credits available

Presenter(s):

G. Michael Allan MD CCFP James McCormack BSc (Pharm) Pharm D Ricky D. Turgeon BSc(Pharm) ACPR PharmD

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • G. Michael Allan MD CCFP
  • James McCormack BSc (Pharm) Pharm D
  • Ricky D. Turgeon BSc(Pharm) ACPR PharmD

Spearkers do not have any conflicts of interest to declare.